NovaVive Inc. - Canine

Directions Website

NovaVive Inc. - Canine NovaVive offers a regulator-approved immunotherapy for canine mammary cancer in the USA and Canada. NovaVive Inc.

is an animal health immunobiology company with a regulator-approved canine cancer product available to veterinarians in CA and the US.

Cancer treatment in dogs can involve multiple modalities.Immunocidin® is NovaVive’s MCWF -based immunotherapy for canine...
10/03/2026

Cancer treatment in dogs can involve multiple modalities.

Immunocidin® is NovaVive’s MCWF -based immunotherapy for canine oncology, with regulatory approval for treating mammary cancer and promising research in a variety of other cancer types.

For veterinarians considering immunotherapy as part of a patient’s treatment plan, NovaVive provides product information and published research to help inform the conversation.

Explore the canine research library at NovaVive.ca/canine-research, or contact NovaVive to discuss the best approach.


What does “MCWF” mean?Mycobacterium Cell Wall Fraction (MCWF) is the active ingredient in Immunocidin®. MCWF stimulates ...
09/29/2026

What does “MCWF” mean?

Mycobacterium Cell Wall Fraction (MCWF) is the active ingredient in Immunocidin®. MCWF stimulates the immune response, including activation of macrophages and lymphocytes involved in fighting tumor cells.

Research continues to explore the immunomodulatory properties of MCWF and its interaction with the canine immune system.

Find Immunocidin® product information and canine research at NovaVive.ca.


A cancer diagnosis can leave dog owners searching for information with many questions to ask their veterinary team.Immun...
09/25/2026

A cancer diagnosis can leave dog owners searching for information with many questions to ask their veterinary team.

Immunocidin® is currently approved for the intratumoral treatment of mixed mammary tumors and mammary adenocarcinoma in dogs, but research has extended into other areas of canine oncology. Studies have explored its use in dogs with cancers including lymphoma, osteosarcoma and transitional cell carcinoma.

While these additional applications remain investigational, continued research helps veterinarians learn more about where immunotherapy may have a role in canine cancer care.

For dog owners, that means the science continues to move forward, building our understanding of immunotherapy and its potential applications in veterinary oncology.

Explore NovaVive’s canine research data at NovaVive.ca/canine-research.

Meet Leeloo, an 8-year-old Rottweiler from Mount Pearl, Newfoundland and Labrador, who was diagnosed with osteosarcoma o...
09/18/2026

Meet Leeloo, an 8-year-old Rottweiler from Mount Pearl, Newfoundland and Labrador, who was diagnosed with osteosarcoma of the forelimb in August 2024.

More than two years later, Leeloo has received Immunocidin® therapy for over 95 weeks and she’s still busy doing what she loves.

“Leeloo competed in another scent detection competition this weekend and gained two new titles. She’s a pro!” - Leeloo’s owner

We love hearing updates like this and seeing Leeloo continue to compete, earn new titles and enjoy time with her family. 💛

📌 Name: Leeloo | Age: 8 | Diagnosis: Osteosarcoma | Immunocidin® Therapy: 95+ weeks

Learn more about Immunocidin® and NovaVive’s canine cancer research at NovaVive.ca.

You know your dog better than anyone and that means you're often the first to notice a new lump, swelling, or when a sub...
09/16/2026

You know your dog better than anyone and that means you're often the first to notice a new lump, swelling, or when a subtle change arises. While not every mass is serious, it's always worth discussing new findings with your veterinarian.

Routine examinations and early conversations help ensure your veterinary team has the information needed to determine appropriate next steps for treatment.

Learn more about Immunocidin® immunotherapy for canine mammary tumors and success stories in various tumor types at NovaVive.ca/products.


Every cancer patient presents a unique set of considerations, which is why veterinarians rely on individualized treatmen...
08/26/2026

Every cancer patient presents a unique set of considerations, which is why veterinarians rely on individualized treatment plans.

Immunocidin® is an immunotherapeutic available for the treatment of canine mammary tumors. By stimulating the innate immune response, it provides veterinarians with another treatment option.

Clinical evaluation in the licensing study found that 88% of dogs receiving Immunocidin® as a sole treatment remained tumor-free two years after treatment.

Discover more about Immunocidin® at NovaVive.ca/products.

Cancer treatment isn't one-size-fits-all, and veterinary medicine continues to provide clinicians with a growing range o...
08/20/2026

Cancer treatment isn't one-size-fits-all, and veterinary medicine continues to provide clinicians with a growing range of treatment options.

Immunocidin® is an immunotherapeutic treatment designed to stimulate the body's innate immune response to fight cancer. It provides veterinarians with another option to consider when developing treatment plans for eligible canine patients.

Explore the science behind Immunocidin® and download the product brochure at NovaVive.ca/products.

Every patient is different, which is why veterinarians appreciate having multiple tools available when developing treatm...
08/18/2026

Every patient is different, which is why veterinarians appreciate having multiple tools available when developing treatment plans.

NovaVive manufactures immunotherapeutic products designed to support veterinarians across equine, canine, and bovine medicine through innovative immune system science.

Learn more about our products and research at NovaVive.ca.

When a dog receives a mammary cancer diagnosis, every decision becomes an important one.Immunocidin® is an immunotherape...
08/14/2026

When a dog receives a mammary cancer diagnosis, every decision becomes an important one.

Immunocidin® is an immunotherapeutic product available to veterinarians for the treatment of canine mammary tumors and may be incorporated into a treatment plan, as determined by the attending veterinarian.

Every patient is unique, and treatment decisions should always be based on an individual dog's condition and overall health.

Learn more about Immunocidin® at NovaVive.ca/products.

In Loving Memory of Max 🐾Max was a 15-year-old American Pit Bull Terrier from Golden, Colorado who was diagnosed with tr...
08/04/2026

In Loving Memory of Max 🐾

Max was a 15-year-old American Pit Bull Terrier from Golden, Colorado who was diagnosed with transitional cell carcinoma (TCC) of the bladder in October 2020.

He passed away on June 16, 2026... 292 weeks after beginning Immunocidin® therapy.

"We never imagined we'd have almost six more years with him. We are thankful to NovaVive for providing the Immunocidin we believe gave us so much extra time together. We are heartbroken without him and forever grateful he was ours." – Max's family

Our heartfelt condolences go out to Max's family. Thank you for allowing us to be a small part of Max's journey. ❤️

Every case is unique. Learn more and read the full product brochure at NovaVive.ca/products.


Address

15 Dairy Avenue
Napanee, ON
K7R1M4

Website

Alerts

Be the first to know and let us send you an email when NovaVive Inc. - Canine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share